- Prior to leading ODH, Michael served as vice president, global commercialization and portfolio management at Otsuka Pharmaceutical and led the company’s global digital strategy.
- Before that, as president and CEO of Kinematik, he successfully grew the R&D software company.
- Throughout his career, he has held key leadership positions at Bristol-Myers, Pharmacia/Pfizer, Warner-Lambert/Pfizer and Wyeth.
Michael Jarjour
—
by
Michael Jarjour is president and CEO of ODH, Inc., a health technology company providing data aggregation and analytics solutions that enable the delivery of integrated health care. He oversees ODH’s overall operations and drives strategy for its flagship product, Mentrics, a clinically-focused technology platform that integrates social determinants, behavioral, physical, pharmacy and other health data into actionable insights for the health industry.
With more than 20 years of experience in pharmaceutical and healthcare technology, Michael has a proven track record of growing businesses, maximizing revenues and building highly motivated, effective management teams on a global scale.